Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Suppression of tumor growth by palm tocotrienols via the attenuation of angiogenesis.

Weng-Yew W, Selvaduray KR, Ming CH, Nesaretnam K.

Nutr Cancer. 2009;61(3):367-73. doi: 10.1080/01635580802582736.

PMID:
19373610
2.

Palm tocotrienols inhibit proliferation of murine mammary cancer cells and induce expression of interleukin-24 mRNA.

Selvaduray KR, Radhakrishnan AK, Kutty MK, Nesaretnam K.

J Interferon Cytokine Res. 2010 Dec;30(12):909-16. doi: 10.1089/jir.2010.0021.

PMID:
21121862
3.

Palm tocotrienols decrease levels of pro-angiogenic markers in human umbilical vein endothelial cells (HUVEC) and murine mammary cancer cells.

Selvaduray KR, Radhakrishnan AK, Kutty MK, Nesaretnam K.

Genes Nutr. 2012 Jan;7(1):53-61. doi: 10.1007/s12263-011-0223-0.

4.

Antiangiogenic effect of celastrol on the growth of human glioma: an in vitro and in vivo study.

Zhou YX, Huang YL.

Chin Med J (Engl). 2009 Jul 20;122(14):1666-73.

PMID:
19719969
5.

Tocotrienols inhibit the growth of human breast cancer cells irrespective of estrogen receptor status.

Nesaretnam K, Stephen R, Dils R, Darbre P.

Lipids. 1998 May;33(5):461-9.

PMID:
9625593
6.

In vivo angiogenesis is suppressed by unsaturated vitamin E, tocotrienol.

Nakagawa K, Shibata A, Yamashita S, Tsuzuki T, Kariya J, Oikawa S, Miyazawa T.

J Nutr. 2007 Aug;137(8):1938-43.

7.

Palm oil tocotrienol fractions restore endothelium dependent relaxation in aortic rings of streptozotocin-induced diabetic and spontaneously hypertensive rats.

Muharis SP, Top AG, Murugan D, Mustafa MR.

Nutr Res. 2010 Mar;30(3):209-16. doi: 10.1016/j.nutres.2010.03.005.

PMID:
20417882
8.

Anti-angiogenic function of tocotrienol.

Miyazawa T, Shibata A, Nakagawa K, Tsuzuki T.

Asia Pac J Clin Nutr. 2008;17 Suppl 1:253-6.

9.

Anti-angiogenic quassinoid-rich fraction from Eurycoma longifolia modulates endothelial cell function.

Al-Salahi OS, Kit-Lam C, Majid AM, Al-Suede FS, Mohammed Saghir SA, Abdullah WZ, Ahamed MB, Yusoff NM.

Microvasc Res. 2013 Nov;90:30-9. doi: 10.1016/j.mvr.2013.07.007.

PMID:
23899415
10.

Antiangiogenic potency of vitamin E.

Miyazawa T, Tsuzuki T, Nakagawa K, Igarashi M.

Ann N Y Acad Sci. 2004 Dec;1031:401-4.

PMID:
15753181
11.

12-Deoxyphorbol 13-palmitate inhibit VEGF-induced angiogenesis via suppression of VEGFR-2-signaling pathway.

Xu HY, Pan YM, Chen ZW, Lin Y, Wang LH, Chen YH, Jie TT, Lu YY, Liu JC.

J Ethnopharmacol. 2013 Apr 19;146(3):724-33. doi: 10.1016/j.jep.2013.01.007.

PMID:
23434607
12.

Tocotrienol-rich fraction of palm oil induces cell cycle arrest and apoptosis selectively in human prostate cancer cells.

Srivastava JK, Gupta S.

Biochem Biophys Res Commun. 2006 Jul 28;346(2):447-53.

PMID:
16762318
14.

Impact of ER520, a candidate of selective estrogen receptor modulators, on in vitro cell growth, migration, invasion, angiogenesis and in vivo tumor xenograft of human breast cancer cells.

Wang L, Wang Y, Du H, Jiang Y, Tang Z, Liu H, Xiang H, Xiao H.

Cancer Chemother Pharmacol. 2015 Dec;76(6):1247-57. doi: 10.1007/s00280-015-2838-0.

PMID:
26464351
15.

Dose-response impact of various tocotrienols on serum lipid parameters in 5-week-old female chickens.

Yu SG, Thomas AM, Gapor A, Tan B, Qureshi N, Qureshi AA.

Lipids. 2006 May;41(5):453-61.

PMID:
16933790
16.

FP3: a novel VEGF blocker with anti-angiogenic and anti-tumor effects.

Gao W, Jin K, Lan H, Han N, Cao F, Teng L.

Hepatogastroenterology. 2012 Nov-Dec;59(120):2543-7.

PMID:
22534543
17.

Plumbagin inhibits tumour angiogenesis and tumour growth through the Ras signalling pathway following activation of the VEGF receptor-2.

Lai L, Liu J, Zhai D, Lin Q, He L, Dong Y, Zhang J, Lu B, Chen Y, Yi Z, Liu M.

Br J Pharmacol. 2012 Feb;165(4b):1084-96. doi: 10.1111/j.1476-5381.2011.01532.x.

18.

Tocotrienol-rich fraction from palm oil affects gene expression in tumors resulting from MCF-7 cell inoculation in athymic mice.

Nesaretnam K, Ambra R, Selvaduray KR, Radhakrishnan A, Reimann K, Razak G, Virgili F.

Lipids. 2004 May;39(5):459-67.

PMID:
15506241
19.

Antiproliferative and apoptotic effects of tocopherols and tocotrienols on normal mouse mammary epithelial cells.

McIntyre BS, Briski KP, Tirmenstein MA, Fariss MW, Gapor A, Sylvester PW.

Lipids. 2000 Feb;35(2):171-80.

PMID:
10757548
20.

Anti-angiogenic properties of a sulindac analogue.

Pyriochou A, Tsigkos S, Vassilakopoulos T, Cottin T, Zhou Z, Gourzoulidou E, Roussos C, Waldmann H, Giannis A, Papapetropoulos A.

Br J Pharmacol. 2007 Dec;152(8):1207-14.

Supplemental Content

Support Center